Dr. Sneha Shrivastava, MD

Dr. Shrivastava practices at Stony Brook Primary Care Center - East Setauket in East Setauket, New York.

Dr. Shrivastava's NPI, 1396033015, was assigned on July 14, 2011. Dr. Shrivastava holds New York license 275829.

Dr. Shrivastava's primary practice is Stony Brook Primary Care Center - East Setauket, at 205 N Belle Meade Rd, East Setauket, NY 11733. The practice phone is (631) 444-4630.

Dr. Shrivastava's primary practice is Stony Brook Primary Care Center - East Setauket in East Setauket, New York. Dr. Shrivastava is also affiliated with Stony Brook University Hospital. The medical group on file is Stony Brook Internists. Dmand AI also links Dr. Shrivastava to 2 more medical groups and 1 group practice or clinic, each named with a free account. Dr. Shrivastava's employer is on file too: a clinical lab.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Shrivastava practices, 3 sites in all. Vendor and product names are available with a free account.

Internal medicine is Dr. Shrivastava's primary specialty in the NPI Registry, under taxonomy code 207R00000X. Dmand AI has Dr. Shrivastava's licenses on file in 2 states: New York and Pennsylvania.

CMS data shows 56 Medicare services from Dr. Shrivastava across 2 procedure codes in 2024, all of them office visits, for 68 Medicare patients. Medicare paid $3,566 for them. Every service was in an office.

CMS counts 68 Medicare patients who saw Dr. Shrivastava in 2024. The largest group is 65 to 74, with 23 patients. 75% of them have high blood pressure, and 63% have high cholesterol. 81% are also on Medicaid. Their average risk score is 1.59, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Shrivastava's median patient age at 51, with 60% women.

In 2024, Dr. Shrivastava wrote 856 Medicare Part D claims for 192 patients. 83% of them were for generic drugs. CMS names the drug for 469 of them, across 22 drugs with 11 or more claims each, at $48,186 in total drug cost. In 2023, CMS named 435 claims across 22 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 93 out of 100 for Dr. Shrivastava for performance year 2024, reported through an alternative payment model (APM). Dr. Shrivastava accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Shrivastava as offering telehealth.

Dmand AI links 3 papers to Dr. Shrivastava, published from 2022 to 2025. The most frequent topics are Curriculum. Dr. Shrivastava's most frequent co-authors are Kalyani Dhar, MD and Abby Lyn Spencer, MD.